10 Jefferies Group Ionis Pharmaceuticals Trades
Jefferies Group's position in Ionis Pharmaceuticals is currently worth $737 Thousand. That's 0.01% of their equity portfolio (616th largest holding). The first Ionis Pharmaceuticals trade was made in Q4 2022. Since then Jefferies Group bought shares four more times and sold shares on five occasions. The investor's estimated purchase price is $944 Thousand, resulting in a loss of 22%.
News about Ionis Pharmaceuticals Inc and Jefferies Group
Medical Tricorder Market to Exceed USD 4.12 Billion by 2027 Globally |CAGR: 5.41%| Industry Overview by Top Players - Scanadu, Quantu MDx Group Ltd., Ibis Bioscience, Ionis Pharmaceutical, Cloud DX, Qualcomm Technologies Inc., Basil Leaf Technologies LLC
A comprehensive overview of the Medical Tricorder Market is recently added by UnivDatos Market Insights to its humongous database. The Medical Tricorder Mark...
Global Hereditary Angioedema Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Pharming Group NV, iBio Inc., Takeda, CSL Limited, Ionis Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc.
The report on Global Hereditary Angioedema Market has been provided by researchers for a detailed understanding of market performance over an estimated perio...